logo
Select company
Select metric
$ -50.95MConsolidated Income
VS
Market
19
Sector
38
Industry
49
History
70
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information

Ticker

BTAI

Company Name

BIOXCEL THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BIOXCEL THERAPEUTICS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BTAI - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -50.95M
3/31/2025$ -40.06M
12/31/2024$ -59.6M
9/30/2024$ -71M
6/30/2024$ -107.83M
3/31/2024$ -153.05M
12/31/2023$ -179.05M
9/30/2023$ -211.6M
6/30/2023$ -202.92M
3/31/2023$ -187.08M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -69.36M.
  • Over the past 5 years, BIOXCEL THERAPEUTICS INC's average Cons. Inc. has been $ -117.69M.
  • The median Cons. Inc. for BIOXCEL THERAPEUTICS INC during this period was $ -107.38M
  • BIOXCEL THERAPEUTICS INC reached its highest Cons. Inc. over the past 5 years at $ -40.06M.
  • The lowest Cons. Inc. recorded by BIOXCEL THERAPEUTICS INC in the same timeframe $ -211.6M

BIOXCEL THERAPEUTICS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
VTGN : VISTAGEN THERAPEUTICS INC $ -55.78MCOYA : COYA THERAPEUTICS INC $ -20.34MAVTX : AVALO THERAPEUTICS INC $ -46.22MADVM : ADVERUM BIOTECHNOLOGIES INC $ -183.87MRNXT : RENOVORX INC $ -10.66MOTLK : OUTLOOK THERAPEUTICS INC $ -43.44MABVC : ABVC BIOPHARMA INC $ -3.28MSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ -13.56MRLYB : RALLYBIO CORP $ -41.65MDTIL : PRECISION BIOSCIENCES INC $ -78.25M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

BTAI - Consolidated Income, Last 5 years

$ -211.6M

Minimum

Sep 30, 2023

$ -40.06M

Maximum

Mar 31, 2025

$ -117.69M

Average

$ -107.38M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M